To fortify the prognostic validity of our model, we enlisted a clinical cohort comprising 20 heterogeneous HNSCC patients, aiming to authenticate the expression patterns of the quartet genes (JCHAIN, GZMB, IGHA1, and PRDX4). This evidence concerns the gene PRDX4 and head and neck squamous cell carcinoma.